Brain-Spinal Cord-Muscle Response Training for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
The study team is currently recruiting volunteers who are interested in participating in a brain-spinal cord-muscle response training study that aims to better understand the changes that take place in the nervous system as a result of this type of training. After spinal cord injury, brain-to-muscle connections are often interrupted. Because these connections are important in movement control, when they are not working well, movements may be disturbed. Researchers have found that people can learn to strengthen these connections through training. Strengthening these connections may be able to improve movement control and recovery after injuries. Research participants will be asked to stand, sit, and walk during the study sessions. Electrodes are placed on the skin over leg muscles for monitoring muscle activity. For examining brain-to-muscle connections, the study team will use transcranial magnetic stimulation. The stimulation is applied over the head and will indirectly stimulate brain cells with little or no discomfort. Participation in this study requires approximately three sessions per week for four months, followed by two to three sessions over another three months. Each session lasts approximately 1 hour.
Will I have to stop taking my current medications?
The trial expects that you will continue your current medications without change for at least 3 months. Stable use of anti-spasticity medication is also accepted.
What data supports the effectiveness of the treatment Brain-Spinal Cord-Muscle Response Training for Spinal Cord Injury?
Research shows that operant conditioning, a key part of this treatment, can increase muscle activity and improve movement in people with spinal cord injuries by enhancing the pathways in the brain and spinal cord that control movement. This suggests that the treatment could help improve motor function recovery in these patients.12345
Is the Brain-Spinal Cord-Muscle Response Training for Spinal Cord Injury safe for humans?
Research on similar treatments, like operant conditioning and targeted plasticity interventions, shows they are generally safe for humans. Studies involving people with spinal cord injuries and other conditions have not reported significant safety concerns, suggesting these methods are safe when conducted under proper protocols.12567
How is the treatment Operant Conditioning different from other treatments for spinal cord injury?
Operant Conditioning is unique because it uses a training method to enhance the brain-spinal cord-muscle connection by encouraging specific muscle responses, which can lead to improved motor function recovery. Unlike other treatments, it focuses on targeted plasticity (the brain's ability to change and adapt) in specific pathways, potentially offering a novel way to improve movement control after spinal cord injury.23458
Research Team
Aiko K Thompson, PhD
Principal Investigator
Medical University of South Carolina
Eligibility Criteria
This trial is for individuals with spinal cord injury who can move at least 10 meters with or without help, have weak ankle movement, and are stable on their current medications. They should be over a year post-injury and neurologically stable. People with severe heart conditions, cognitive impairments, seizures, metal head implants, no muscle response in tests, daily leg stimulation therapy or pregnancy cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo brain-spinal cord-muscle response training to strengthen brain-to-muscle connections
Extended Training
Continued training sessions to further enhance brain-to-muscle connections
Follow-up
Participants are monitored for changes in reflexes, muscle activation, and walking ability
Treatment Details
Interventions
- Operant Conditioning
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator